General Summary
MK-8527-010 project is “A Phase 3, Randomized, Active-controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral MK-8527 as HIV-1 Preexposure Prophylaxis in Cisgender Women”.
Key Responsibilities
- Responsible for overall coordination of the MK8527 Study functions; clinical, pharmacy, counseling, recruitment, retention, and home visits.
- Responsible for developing work plans and implementation schedules, and ensuring that the study’s aims and objectives, including recruitment, follow up, retention, and adherence, are achieved.
- Performs clinical study procedures
- Primarily responsible for managing and reporting adverse events.
- Provides protocol guidance to staff and is responsible for developing standard operating procedures (SOPs) for the study.
- Responsible for study related outreach activities, sensitization of the communities and liaising with the Community Advisory Group.
- Coordinates study related communications and regulatory boards
- Ensures submission of study progress and performance reports to the Principal Investigator.
- Attends study meetings
- Performs other duties as assigned by the Principal Investigator
Academic Qualifications
- • Must be a registered Medical Doctor (MBChB
- • Up-to-date Good Clinical Practice training and certification
Person Specification
- An excellent track record of high ethical standards and professionalism.
- Females are encouraged to apply.
- Good communication skills
- Good problem-solving skills
- Conversant with local language (Luganda)
- Flexibility
Residents of Kalangala are encouraged to apply.
